Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Inserm
This publication has 115 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Recapitulation of premature ageing with iPSCs from Hutchinson–Gilford progeria syndromeNature, 2011
- Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2010
- Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patientsMechanisms of Ageing and Development, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Increased expression of the Hutchinson–Gilford progeria syndrome truncated lamin A transcript during cell agingEuropean Journal of Human Genetics, 2009
- Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson–Gilford progeria syndrome mutationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human agingProceedings of the National Academy of Sciences, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature agingProceedings of the National Academy of Sciences, 2006